Ferroptosis: An Emerging Target for Bladder Cancer Therapy

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Bladder cancer (BC) is a major urological malignancy with significant challenges in drug resistance and metastasis.
• Current understanding and therapeutic strategies for BC prognosis require further advancement.
• Ferroptosis, a form of regulated cell death, is increasingly recognized for its role in cancer.

Purpose of the Study:

• To review the underlying mechanisms of ferroptosis in the context of bladder cancer.
• To explore the potential of ferroptosis as a novel therapeutic strategy for BC.
• To identify related therapeutic targets and drugs for BC based on ferroptosis pathways.

Main Methods:

• Literature review focusing on ferroptosis mechanisms (lipid peroxidation, antioxidant system, iron overload).
• Analysis of the correlation between ferroptosis and BC development, progression, and treatment.
• Identification of potential therapeutic targets and drugs associated with ferroptosis in BC.

Main Results:

• Ferroptosis is strongly correlated with the development and treatment of bladder cancer.
• The key mechanisms of ferroptosis involve lipid peroxidation, antioxidant systems, and iron metabolism.
• Emerging evidence suggests ferroptosis can overcome multi-drug resistance in BC.

Conclusions:

• Ferroptosis presents a promising novel therapeutic avenue for bladder cancer.
• Targeting ferroptosis pathways may offer new strategies to combat BC drug resistance and metastasis.
• Further research into ferroptosis mechanisms and therapeutic interventions is warranted for BC treatment.